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Summary. The present study was designed to further 
characterize the muscarinic receptors mediating contrac-
tion of the guinea-pig uterus. The affinities of various 
selective muscarinic antagonists were determined and 
compared with those obtained at M 1 (rabbit vas 
deferens), M 2 (guinea-pig atria) and M 3 receptors 
(guinea-pig ileum). 
The contractile responses of uterine smooth muscle 
from immature guinea-pigs to carbachol (pD 2 = 5.73) 
were competitively antagonized by pirenzepine (pA2 = 
7.04), AF-DX 116 (11-[[2-[(diethylamino)methyl]-1-piper-
idinyl]acetyl]- 5,11-dihydro-6H -pyrido[2,3-b][1 ,4]benzo. 
diazepin-6-one) (pA2 = 6.96), himbacine (pA2 = 7.92), 
methoctramine (pA2 = 7.52), 4-DAMP (4-diphenylace-
toxy-N-methylpiperidine methiodide) (pA2 = 8.87) and 
sila-hexocyclium (pA2 = 8.81). A comparison of affinity 
values indicates that the muscarinic receptors present in 
guinea-pig uterus display a novel pharmacological profile 
which is not consistent with the presence of either an M 1 , 
M 2 or M 3 receptor. The affinities determined for the 
different antagonists rather showed a close similarity to 
those obtained at muscarinic receptors present in rat 
striatum and NG108-15 cells which are considered phar-
macological equivalents (M4 receptors) of the m4 gene 
product. We thus hypothesize that the guinea-pig isolated 
uterus preparation may serve as a simple functional assay 
system to study the pharmacology of M 4 receptors. 
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Introduction 
Radioligand binding as well as in vitro andin vivo func-
tional studies have revealed the existence of at least three 
pharmacologically distinct musearlnie receptor subtypes, 
which have been termed Mb M 2 and M 3 (Doods et al. 
1987; Mitchelson 1988; Levine and Birdsall 1989). M 1 
receptors are mainly present in neuronal tissues (e. g. 
autonomic ganglia, cerebral cortex and hippocampus) 
and are characterized by a high affinity for pirenzepine 
(affinity profile M 1 > M3 ;?: M 2 ) (Hammer et al. 1980; 
Hammer and Giachetti 1982). M 2 and M 3 receptors are 
primarily found in lower brain areas and in peripheral 
effector argans such as heart (M2), smooth muscle (M 3) 
and glands (M3) and display low affinity for piren-
zepine. They can be distinguished by the use of selective 
antagonists such as methoctramine and AF-DX 116 
(M2 > M 1 > M 3) (Melchiorre et al. 1987; Waelbroeck et 
al. 1989; Hammer et al. 1986; Micheletti et al. 1987), 
himbacine (M1 ~ M 2 > M 3) (Gilani and Cobbin 1986; 
Lazareno and Roberts 1989), sila-hexocyclium (M 1 
~ M 3 > M 2) (Eltze et al. 1988; Waelbroeck et al. 1989), 
4-DAMP and hexahydro-sila-difenidol (M3 ::?:: M 1 > M 2) 
(Barlow et al. 1976; Mutschier and Lambrecht 1984; 
Lambrecht et al. 1989). 
The pharmacology of the M 1, M 2 and M3 receptors 
closely corresponds to that of the m1, m2 and m3 receptor 
subtypes, respectively, identified by recent receptor 
cloningsturlies (Akiba et al. 1988; Buckley et al. 1989). 
Recombinant DNA technology has also revealed the exis-
tence oftwo additional muscarinic receptor subtypes, m4 
and m5, whose pharmacology has not been studied in 
detail so far (Banner et al. 1987, 1988; Peralta et al. 1987). 
Recently, Eglen et al. (1989) suggested that the con-
tractile response to carbachol in the guinea-pig estrogen-
dominated uterus is mediated by a homogenaus popu-
lation of M 2 receptors. As smooth muscle contraction is 
usually mediated by M 3 receptors (Mitchelson 1988), we 
have reevaluated this finding using a larger nurober of 
selective antagonists. The affinity values obtained in uteri 
from immature guinea-pigs were compared to those 
obtained at M 1 receptors in rabbit vas deferens, M 2 re~ 
ceptors in guinea-pig atria and smooth muscle M 3 recep~ 
tors in guinea-pig ileum. Our data arenot consistent with 
the presence of an Mb M 2 or M 3 receptor in the guinea-
pig uterus but suggest that the pharmacology of the uter-
ine muscarinic receptor is most closely related to that 
present in NG108-15 cells (Michel et al. 1989) and rat 
striatum (McKinney et al. 1989; Waelbroeck et al. 1990), 
which is considered the pharmacological correlate (M4 
receptor) of the m4 gene product. 
Methods 
Guinea-pig isolated uterus. Immature guinea-pigs (Pirbright-white, 
190-220 g, 3-4 weeks old) were killed by a blow on the head and 
uterine homs were excised and separated from fat deposits and 
mesenteric attachments. Uterine horns were suspended under 1.0 g 
tension in 7 ml tissue baths containing oxygenated (95% 0 2 + 5% 
C02) Sund's physiological salt solution (mmol/1: NaC1154.0, KCI 
5.63, CaCI2 0.54, MgCh 0.95, NaHC03 5.95, ( + )-glucose 2. 78). The 
preparations were maintained at 30° C and after 1 h equi1ibration 
period, isotonic contractions to carbachol were recorded by a force-
displacement transducer connected to a Heilige amplifier and a 
Rikadenki multichannel recorder. Initially, the tissues were exposed 
to a single concentration of carbachol (3 J.lmo1/l) to check the respon-
siveness to the agonist. Then two cumulative concentration-response 
curves to carbachol were constructed, one in the absence and one 
in the presence of antagonist. In separate control experiments, no 
significant changes in tissue sensitivity to the agonist was observed 
over the period necessary for the determination of two concen-
tration-response curves. 
Rahbit isolated vas deferens. Experiments on rabbit isolated vas 
deferens were performed according to Eltze (1988). Male New 
Zealand white rabbits (2.5- 3.0 kg) were killed by i. v. injection of 
120 mg/kg pentobarbitone sodium. Vasa deferentia were excised 
and divided into four segments of approximately 1.5 cm length. The 
preparations were set up in 7 ml organ baths containing modified 
Krebs buffer which consisted of (mmol/1): NaC1 118.0, KCI 4.7, 
CaCI2 1.8, MgS04 0.6, KH 2P04 1.2, NaHC03 25.0 and ( + )-glucose 
11.1; 1 J.lmol/1 yohimbine was included to block cx 2-adrenoceptors. 
The bathing fluid was maintained at 31°C and aerated with 95% 
0 2 + 5% C02 • A basal tension of 750 mg was applied. After a 
30 min equilibration period twitch contractions were elicited by field 
stimulation (0.05 Hz, 0.5 ms, 30 V) with platinum electrodes and 
recorded as described for the isolated uterus. The neuragenie twitch 
contractions were concentration-dependently inhibited by the M 1 
receptor agonist 4-Cl-McN-A-343 [4-(4-chlorophenylcarbamoy1-
oxy)-2-butynyltrimethylammonium iodide] (Eltze et al. 1988). After 
1 h equilibration period, concentration-response curves were con-
structed by adding doses of 4-CJ-McN-A-343 cumulatively. When 
these responses were constant, concentration-response curvcs were 
repeated in the presence of antagonists. 
Guinea-pig isolated atria and ileum. Guinea-pigs (Pirbright-white, 
300-400 g) of either sex were killed by cervical dislocation. Left 
atria and ileallongitudinal muscle strips (Paton and Zar 1968) were 
set up in 6 ml organ baths, under 500 mg tension, in oxygenated 
(95% 0 2 + 5% C02) Tyrode solution (32°C) composed of (mmol/ 
1): NaCI 137.0, KCI 2.7, CaC12 1.8, MgC12 1.05, NaHC03 11.9, 
NaH2 P04 0.42 and ( + )-glucose 5.6. Arecaidine propargyl ester 
(Moseret al. 1989) was used as an agonist. Atria were paced electri-
cally (2 Hz, 3 ms, 5 V) by means of platinum electrodes. Negative 
inotropic effects to the agonist were measured as changes in iso-
metric tension. Responses of ileallongitudinal muscle to arecaidine 
propargyl ester were measured as isotonic contractions. Atrial and 
ileal responses were recorded as with the isolated uterus. After an 1 h 
equilibration period, concentration-response curves to arecaidine 
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propargy1 ester were obtained by use of cumu1ative dosing. When 
two control curves were superimposab1e, cumulative concentra-
tion-response curves were repeated in the presence of antago-
nists. 
Antagonist affinities. Three to four different concentrations of each 
antagonist (log conc. intervals = 0.5) were used. Antagonists were 
allowed to equilibrate for 15-30 min (ileum and uterus), 30-
45 min (atria) or 30-60 min in vas deferens, respectively. Prelimi-
nary experiments indicated that these intervals were sufficient for 
equilibration of the antagonist concentrations used. The uterus 
preparation was exposed to only one concentration of antagonist. 
EC50-values of agonists in the absence and presence of antagonists 
were determined graphically for ca1culation of dose-ratios. The 
slopes of Arunlakshana-Schild plots (Arunlakshana and Schild 
1959) were determined by linear regression by the method of least 
squares. pArvalues were estimated as the intercept on the abscissa 
scale by fitting to the data the beststraight 1ine with a slope ofunity 
(Tallarida and Murray 1986). 
Statistical evaluation. The data are presented as means ± SEM of 
n experiments. Differences between mean values were tested for 
statistical significance by Student's t-test; p < 0.05 was accepted as 
being significant. 
Drugs. The following drugs were used: carbamoylcholine chloride, 
tetrodotoxin and yohimbine hydrochloride (Sigma, München, 
FRG); hexamethonium bromide (Fluka, Buchs, Switzerland); pi-
renzepine dihydrochloride and AF-DX 116 (11-[[2-[(diethyl-
amino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyrido(2,3-
b][l ,4]benzodiazepin- 6- one) (Thomae, Biberach, FRG); himbacine 
hydrochloride (kindly donated by Dr. W. C. Taylor, Sydney, Aus-
tralia); methoctramine tetrahydrochloride (generous gift from Dr. 
C. Melchiorre, Bologna, Italy); 4-DAMP (4-diphenylacetoxy-N-
methylpiperidine methiodide) (kindly donated by Dr. R. B. Barlow, 
Bristo1, UK); sila-hexocyclium methyl sulfate (Tacke et al. 1989), 
4- ( 4- chlorophenylcarbamoy1oxy)- 2- butynyltrimethylammonium 
iodide (4-Cl-McN-A343) (Nelson et al. 1976) and arecaidine propar-
gyl ester (Mutschler and Hultzsch 1973) were synthesized in our 
laboratories. All other chemieals were of reagent grade and used as 
purchased. 
Results 
The contractile responses of the isolated guinea-pig 
uterus to carbachol were not significantly (P > 0.05) af-
fected by the presence oftetrodotoxin (1 f.LIDOl/1) or hexa-
methonium (1 0 Jlmol/1), excluding the involvement of 
neuronal nicotinic or muscarinic receptors ( data not 
shown). 
All antagonists employed concentration-dependently 
inhibited the carbachol-induced contractile responses of 
the isolated guinea-pig uterus (-log EC50 = 5. 73 ± 0.03) 
(Fig. 1) as weil as the negative inotropic responses in 
guinea-pig atria (-log EC50 = 8.12 ± 0.07) and ileal 
contractions (-log EC50 = 7.77 ± 0.04) to arecaidine 
propargyl ester. Likewise, the 4-Cl-McN-A-343-induced 
inhibition of twitch contractions of the rabbit vas 
deferens (-log EC50 = 7.12 ± 0.06) was concentration-
dependently blocked by all antagonists examined. In all 
tissues, parallel shifts of the agonist concentration-re-
sponse curves without any appreciable changes of basal 
tension or reduction of maximum responses were ob-
served. This is shown for pirenzepine, methoctramine and 
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Fig. 1. Cumulative concentration-response curves for carbachol-
induced contractions of the guinea-pig uterus in the absence ( 0) 
and presence ( •) of increasing concentrations of pirenzepine, 
methoctramine and sila-hexocyclium. Nurobers next to the concen-
tration-response curves indicate -log molar antagonist concen-
trations. Contractile responses to each concentration of agonist are 
expressed as a percentage of the maximum contraction induced 
by carbachol. The data points represent mean of n = 3-5 Ob-
servations (SEM are given as vertical bars if larger than symbol 
size) 
sila-hexocyclium in Fig. 1. Arunlakshana-Schild plots 
were linear through the concentration range tested for 
each antagonist and slopes were not significantly different 
from unity (p > 0.05) (Table 1). Thus, all compounds be-
haved as competitive muscarinic antagonists in all prep-
arations used. The pArvalues determined for the various 
antagonists are shown inTable 1. As indicated, some data 
are taken from work previously published (Lambrecht et 
al. 1989; Waelbroeck et al. 1989). A comparison of pAr 
values reveals that the antagonist affinities obtained at 
uterine muscarinic receptors of the guinea-pig do not 
correlate well with those determined at Mb M2 or M3 
receptors (Table 1, Fig. 2A- C). 
Discussion 
Receptor binding studies suggest that smooth muscle of 
the ileum (Giraldo et al. 1988), urinary. bladder 
(Monferini et al. 1988) and trachea (Roffel et al. 1989) 
have both M2 and M3 receptors. Functionally, however, 
smooth muscle contraction appears to be mediated 
through M3 receptors only (Mitchelson 1988). In cantrast 
to these reports, Eglen et al. (1989) suggested that the 
muscarinic receptor mediating smooth muscle contrac-
tion of the guinea-pig uterus is of the M2 type. Wehave 
reevaluated this controversial finding using a larger num-
ber of selective antagonists. The affinities obtained at 
uterine muscarinic receptors of immature guinea-pigs 
were compared to those determined at M 1 (rabbit vas 
deferens), M2 (guinea-pig atria) and M3 receptors 
(guinea-pig ileum). 
The antimuscarinic potencies of the antagonists at 
Mb M2 and M3 receptors (pArvalues, Table 1) werein 
good agreement with their affinity estimates determined 
in radioligand binding studies (Lazareno and Roberts 
1989; Waelbroeck et al. 1989) and previous functional 
studies (Barlow et al. 1976; Gilani and Cobbin 1986; 
Micheletti et al. 1987; Eltze 1988; Eltze et al. 1988; 
Waelbroeck et al. 1989; Lambrecht et al. 1989). A com-
parison of these affinity values with those determined at 
uterine muscarinic receptors suggests that the muscarinic 
receptor mediating contractions of the guinea-pig uterus 
is pharmacologically unique (Table 1 ). As discussed be-
low, its profile is not consistent with the presence of an 
Mt, M2 or M3 receptor in this tissue. Moreover, since 
the slopes of Arunlakshana-Schild regression lines did 
not significantly differ from unity, the presence of a het-
erogeneaus mixture of these subtypes appears to be un-
likely (Table 1). This conclusion is further supported by 
radioligand binding studies which have identified a 
homogeneaus population of muscarinic binding sites in 
the guinea-pig uterus (Eglen et al. 1989). 
The affinity of pirenzepine (pA2 = 7 .04) for uterine 
muscarinic receptors was 16-fold lower than that ob-
served at M 1 receptors in vas deferens, excluding the 
presence of M 1 receptors (Table 1, Fig. 2A). Further-
more, uterine muscarinic receptors displayed high affinity 
for AF-DX 116 (pA2 = 6.96), himbacine (pA2 = 7.92) 
and methoctramine (pA2 = 7 .52). Their pArvalues 
closely approached those obtained in guinea-pig atria 
(Fig. 2 B) but were 3-, 4- and 24-fold higher, respectively, 
than observed at ileal M3 receptors (Fig. 2C). These data, 
in conjunction with the low affinity found for 
pirenzepine, would indicate a high similarity of the uter-
ine receptors to cardiac M2 receptors. However, the high 
antimuscarinic potencies of the selective antagonists 4-
DAMP (pA2 = 8.87) and sila-hexocyclium (pA2 = 8.81) 
do not fit into this concept. These antagonists show a 3-
and 17-fold higher affinity for muscarinic receptors in the 
uterus than for atrial M2 receptors (Fig. 2B). 
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Table 1. pArvalues and slopes of Arunlakshana-Schild plots (in parentheses) for various selective muscarinic antagonists at M 1, M2 , M 3 
and guinea-pig uterine muscarinic receptors 
Compound Rahbit vas Guinea-pig Guinea-pig Guinea-pig 
deferens (M1) atria (M2) ileum (M3) uterus 
Pirenzepine 8.24 ± 0.06* 6.82 ± 0.03* 6.88 ± 0.04* 7.04 ± 0.02 
(1.19 ± 0.10) (0.98 ± 0.02) (1.07 ± 0.04) (1.00 ± 0.03) 
[n = 14; 14] 
AF-DX 116 7.12 ± 0.04 7.36 ± 0.05 6.48 ±0.04 6.96 ± 0.03 
(1.07 ± 0.08) {0.89 ± 0.08) (0.93 ± 0.07) (0.92 ± 0.05) 
[n = 8; 4] [n = 8; 8] [n = 10; 9] [n = 12; 12] 
Himbacine 8.17 ± 0.04 8.09 ± 0.04 7.34 ±0.05 7.92 ± 0.03 
(1.02 ± 0.06) (0.86 ± 0.07) (0.93 ± 0.08) (0.99 ± 0.05) 
[n = 13; 7] [n = 8; 8] [n = 8; 4] [n = 19; 19] 
Methoctramine 6.85 ± 0.07* 7.69 ± 0.03* 6.17 ±0.05* 7.51 ± 0.03 
(1.19 ± 0.10) (1.05 ± 0.05) (0.99 ± 0.09) (0.97 ± 0.04) 
[n = 15; 15] 
4-DAMP 9.39 ± 0.06 8.40 ± 0.05 9.34 ± 0.05 8.87 ± 0.01 
(1.09 ± 0.12) (0.93 ± 0.08) (0.91 ± 0.05) (1.01 ± 0.02) 
[n = 8; 6) [n = 8; 8] [n = 8; 8] [n = 18; 18] 
Sila-Hexocyclium 9.04 ± 0.03 7.57 ± 0.04** 8.78 ± 0.05** 8.81 ± 0.03 
(1.07 ± 0.06) (0.94 ± 0.07) {1.04 ± 0.09) (0.97 ± 0.05) 
[n = 8; 6] [n = 16; 16] 
The data are presented as means ±SEM. The slopes of Arunlakshana-Schild plots were calculated by linear regression analysis (Tallarida 
and Murray 1986). pA2-values were obtained after the unity constraint bad been imposed. The number of total data points (n) and tissues 
used are given in square brackets. The slopes shown are not significantly different from unity (p > 0.05). * Data taken from Lambrecht et 
al. 1989; ** Data previously published {Waelbroeck et al. 1989) 
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Fig. 2 A- D. Comparison of mean antagonist 
affinities {pArvalues, Table 1) obtained for 
pirenzepine (Pz), AF-DX 116, himbacine (Hi), 
methoctramine (Me), 4-DAMP and sila-
hexocyclium (Sihc) at muscarinic receptors in 
guinea-pig uterus to their affinity estimates 
determined at M 1 {A), M 2 (B) and M3 (C) 
receptors. Comparison of mean antagonist 
affinities {pAr or pKi·values) obtained in 
functional sturlies in guinea-pig uterus and 
radioligand binding assays at M4 receptors 
present in rat striatum (Waelbroeck et al. 
1990), (D). In case of receptor identity, the 
data points should not significantly deviate 
from the theoretical equality line (y = x). 
The distance to this line (given in Fig. 2A- C 
for pirenzepine, sila-hexocyclium and 
methoctramine as the antilog of the difference 
in pA2-values) is a direct measure of receptor 
selectivity 
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Taken together, the muscarinic receptors present in 
guinea-pig uterus display a novel pharmacological profile 
whose most characteristic features are a low affinity for 
pirenzepine but high affinity for methoctramine and sila-
hexocyclium. 
Recent findings suggest that the muscarinic receptors 
in rat striatum (McKinney et al. 1989; Waelbroeck et al. 
1990) and NG1 08-15 cells (Michel et al. 1989; Baumgold 
and White 1989) are pharmacological equivalents (M4 
receptors) of the m4 gene (Brann et al. 1988; Peralta et 
al. 1987). In Fig. 2D, antagonist affinities (pArvalues) 
for muscarinic receptors in guinea-pig uterus are plotted 
against their binding affinities (pKcvalues) for M4 recep-
tors in rat striatum (Waelbroeck et al. 1990). Conspicu-
ously, the affinity estimates of the antagonists obtained 
in guinea-pig uterus and rat striatum were strikingly simi-
lar. In addition, the binding affinities ofpirenzepine, AF-
DX 116, methoctramine and 4-DAMP at M4 receptors 
in NG108-15 cells (Michel et al. 1989) correlate weil with 
their functional potencies in the guinea-pig uterus (this 
study). 
Biochemical studies with NG108-15 cells (Harden et 
al. 1986) and cloned muscarinic receptors (Peralta et al. 
1988; Ashkenazi et al. 1989) revealed that m4 receptors 
strongly inhibit adenylate cyclase. Moreover, m4 recep-
tors have also been shown to mediate Stimulation of 
phosphoinositide hydrolysis (Peralta et al. 1988; Ash-
kenazi et al. 1989). Both second messenger responses have 
been reported to occur upon muscarinic Stimulation of 
the immature guinea-pig uterus (Leiber et al. 1984; Mare 
et al. 1986). 
We therefore hypothesize that the isolated guinea-pig 
uterus preparation may serve as a simple functional assay 
system to study the pharmacology of M4 receptors. To 
lend further support to this notion, molecular biological 
studies are underway to verify that m4 mRNA is in fact 
expressed in this tissue. 
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